MetaCap

Denali Therapeutics Statistics

NASDAQ: DNLIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

18.45+0.25 (+1.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Denali Therapeutics by the numbers

Denali Therapeutics has a market capitalization of $2.96 billion based on 160.29M shares outstanding. With trailing EPS of $-1.72, Denali Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 12.7% below its 200-day average.

Average daily trading volume is 1.68M shares, or about $30.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DNLI valuation vs. peer median

DNLI compared with the median of 8 peer companies
MetricDNLIPeer medianDifference
Market cap$2.96B$3.06B-3%
Avg. volume1.68M2.49M-33%

Peer median across 8 companies: ADMA, VCEL, IOVA, RLAY, TARS, BEAM, CRSP, BCRX.

Valuation

Price and trading

Previous close
18.20
Open
17.95
Day range
17.92 – 18.85
52-week range
15.34 – 27.30
52-week change
+2.50%
Beta
—
Volume
2.63M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.96B
Forward Pe
-8.17
Eps
-1.72
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
27.30
Week52 Low
15.34
Avg Volume
1.68M
Shares Outstanding
160.29M
Ma50
19.43
Ma200
21.14
Earnings Date
Nov 3, 2026
Pct From52w High
-32.42%
Pct From52w Low
20.27%

Related